Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France.
Euro Surveill. 2010 Nov 25;15(47):19730. doi: 10.2807/ese.15.47.19730-en.
The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of the HPV vaccination into the national immunisation schedules in the 29 participating countries. As of July 2010, 18 countries have integrated this vaccination. The vaccination policy and achievements vary among those countries regarding target age groups, delivery infrastructures and vaccination coverage reached. Financial constraints remain the major obstacle for the 11 countries who have not yet introduced the vaccination.
《威尼斯 2 人乳头瘤病毒疫苗接种调查》评估了 29 个参与国家将 HPV 疫苗纳入国家免疫计划的情况。截至 2010 年 7 月,已有 18 个国家将该疫苗纳入计划。在目标年龄组、提供基础设施和接种覆盖率方面,各国的疫苗接种政策和成果各不相同。11 个尚未引入疫苗的国家仍面临着财政限制这一主要障碍。